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Collectively, our results reveal that PDTþ
PDL reduces the PDT light dose required
to achieve persistent vascular shutdown,
even at low PDL radiant exposures. We
hypothesize that TS-mediated PDT
enhances persistent vascular shutdown
achieved with ensuing PDL therapy, pri-
marily via endothelial cell damage (Mitra
and Foster, 2008); mechanistic studies
currently are underway.
Dual phototherapy represents a poten-
tial new approach for more effective
treatment of PWS birthmarks. We have
initiated a trial approved by the Investiga-
tional Review Board to evaluate intrave-
nously administered TS/664-nm laser
light–mediated dual phototherapy for
PWS treatment. Treatment has been pain-
less and notable lesion lightening has
been achieved with both PDT and
PDTþPDL in a single session. Patients
are photosensitive for 5–7 days post
procedure, and for the first 72hours they
must remain indoors with lights dimmed.
Completion of this study will determine
whether lesion lightening is greater with
dual phototherapy than PDL alone. It is
our intent that this combined low-energy
dual phototherapy will offer clinicians
and patients of all skin types improved
lesion lightening in fewer treatments.
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Multiple Self-Healing Palmoplantar Carcinoma:
A Familial Predisposition to Skin Cancer
with Primary Palmoplantar and Conjunctival Lesions
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TO THE EDITOR
Familial keratoacanthomas (KAs) are
characterized by the appearance of
multiple epithelial tumors that are beli-
eved to arise from adjoining hair folli-
cles (Schwartz, 1994). These lesions,
which phenotypically and histologi-
cally resemble squamous cell carcino-
mas (SCCs) (Cribier et al., 1999), have
a fast evolution and spontaneous
regression. To date, four familial forms
of multiple KAs have been described:
(1) multiple self-healing squamousAccepted article preview online 22 July 2014; published online 11 September 2014
Abbreviations: KA, keratoacanthoma; MSPC, multiple self-healing palmoplantar carcinoma; MSSE,
multiple self-healing squamous epithelioma; SCC, squamous cell carcinoma
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epithelioma (MSSE; Smith, 1948); (2) the
Grzybowski syndrome (Grzybowski,
1950); (3) the Witten–Zak syndrome
(Witten and Zak, 1952); and 4) the
Muir-Torre syndrome (Muir et al.,
1967). The Muir-Torre syndrome
(MIM#158320) is caused by mutations
in the DNA-repair genes MSH2/MLH1
(Bapat et al., 1996; Kruse et al., 1998),
and MSSE (MIM#132800) is due to
mutations in TGFBR1 (Goudie et al.,
2011), but the causative genes under-
lying the other two familial KAs are still
not known.
We describe here, in a five-generation
Tunisian family comprising 27 affected
individuals with autosomal dominant
transmission of palmoplantar KAs, an
unreported syndrome that we have
named multiple self-healing palmoplan-
tar carcinoma (MSPC) (Figure 1).
MSPC has the distinctive feature of
mainly affecting epithelial tissues that
are devoid of hair follicles, such as
palmoplantar skin and the conjunctival
epithelium.
Phenotypically, the development of
skin lesions begins with a progressive
appearance of multiple ulcerative-nod-
ular tumors on plantar skin (Figure 1b–
e). The average age of onset was 8.8
years for the 15 propositi studied and
ranged from 1 to 25 years (Supplemen-
tary Figure S1a online). Palmoplantar
tumors (5–50 mm in diameter, 8–12 in
number) grew over a period of 3 months
and spontaneously regressed after 6
months, leaving atrophic scars consistent
with KAs (Figure 1e). Histological
examination of a primary plantar lesion
and peri-lesional skin of patient IV:2
showed a massive epidermal hyperker-
atosis overlying an endophytic squamo-
proliferative tumor with prominent
keratin cyst formation and crypt
abscesses and a dense stromal inflamma-
tory infiltrate at the base (Supplementary
Figure S1b–f online). Notably, the gran-
ular layer, which is prominent in normal
palmoplantar epidermis, was nearly
absent. Histological findings are
suggestive of a verrucous carcinoma, a
low-grade SCC.
In addition to palmoplantar tumors,
80% of studied propositi also developed
conjunctival lesions, which appeared in
the second decade of life (Figure 1h
and i). All were surgically removed, and
histological examination of one such
tumor revealed squamous epithelial
lobules with a dyskeratotic center, sug-
gestive of a conjunctival KA (data not
shown). The use of retinoids (Etretinate
or Acitretin) halted the progression of
the palmoplantar tumors but also
stopped their self-regression to a final
pitted-scar stage. In cases of resistance
to retinoid treatment, palmoplantar
tumors were operated upon. Despite
these precautions, 5 out of 15 (33%)
affected patients whose medical records
were available had developed malig-
nant tumors in the lungs (III:10) and
head and neck (III:11 and IV:19), SCC
on the nose (IV:5), and SCC with bone
metastasis (IV:2) (Supplementary Figure
S1a online). Patient IV:2 developed
both labial (Figure 2a) and heel SCC,
which infiltrated the calcaneus bone
(Figure 2b–e), requiring bilateral leg
amputation.
On the basis of its autosomal domi-
nant transmission and multiple self-
regressive presentations, we initially
hypothesized that this syndrome could
be a clinically heterogeneous form of
MSSE. However, neither Sanger sequen-
cing of all nine exons of TGFBR1 nor
haplotype mapping of its locus on chro-
mosome 9q22.33 revealed any common
allele shared by all propositi. No DNA-
repair defects were observed consistent
with the patient’s normal karyotypes
and absence of chromatin fragility in
patients’ B-lymphocytes, arguing against
a phenotype related to the Muir-Torre
syndrome.
To unambiguously map the causative
allele for this uncommon genodermato-
sis, we obtained DNA from blood sam-
ples from 11 affected and 5 unaffected
members after obtaining informed writ-
ten consent and Institutional Review
Board approval. Members were single-
nucleotide polymorphism genotyped
using human 660W-Quad BeadChips
from Illumina (Figure 1a), and identity-
by-descent mapping was performed
(Reversade et al., 2009). Assuming
autosomal dominant transmission,
only one identity-by-descent block on
chromosome 17p13.3-p12 was found
to be shared by all genotyped
probands and not by any of the five
unaffected family members tested
(Figure 2f). Meeting genome-wide
significance, parametric and non-para-
metric linkage analyses yielded a maxi-
mum LOD score of 1.69 (Abecasis et al.,
2002) and 4.21 (manual calculation),
respectively. This 11.4 Mb locus
bracketed by single-nucleotide polymor-
phisms rs8065368 and rs2322788
contains 288 genes (GRCh37/hg19:
chr17:1541109-12964181) (Figure 2f)
including TP53, a prominent tumor sup-
pressor often mutated in skin cancer
(Giglia-Mari and Sarasin, 2003). Sanger
sequencing excluded mutations in
TP53, arguing that a hitherto unidenti-
fied causative gene for MSPC lies within
this haplotype.
The combination of clinical presenta-
tions primarily affecting palmoplantar
and conjunctival skin and autosomal
dominant genetic transmission argues
that this syndrome is an inherited
skin disease that to our knowledge is
previously unreported. Six characteris-
tics distinguish MSPC from the other
four familial KA syndromes: (1) the ear-
lier age of onset varying between 1 and
25 years; (2) the primary lesions that do
not arise in sun-exposed areas but rather
at points of pressure and friction; (3) the
presence of conjunctival KA; (4) the
ulcerative-nodular aspects of tumors;
(5) the larger size of tumors, which vary
between 5 and 50 mm; and (6) the
tendency to transform into SCC with
metastases, a feature only seen in MSSE
patients subjected to radiotherapy
(Chakrabarty and Perks, 1996). These
differences, together with the presence
of exclusive linkage to chromosome
chr.17p13.3-p12, argue that MSPC is
clinically and genetically distinct from
MSSE, other inherited multiple KA, or
punctate palmoplantar-specific geno-
dermatosis (Pohler et al., 2012). To the
best of our knowledge, only one similar
case with multiple self-healing palmo-
plantar lesions has been reported in the
literature (Feldman and Maize, 2007).
Unlike KAs, which are believed to
originate from hair follicles, the
presence of lesions on hairless palmo-
plantar skin and on conjunctival
epithelia argues instead that MSPC can
originate from interfollicular keratino-
cyte progenitors.
We propose that this different syn-
drome should be classified as an inher-
ited predisposition to skin cancer with
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Figure 1. Clinical manifestations of autosomal dominant multiple self-healing palmoplantar carcinoma (MSPC). (a) Pedigree of a five-generation Tunisian family
segregating autosomal dominant MSPC (’: affected man,&: healthy man,J: healthy woman,K: affected woman,’: unknown phenotype, *: propositi having
developed cancer, underlined: genotyped individual). Clinical histories and physical examinations were undertaken after obtaining informed written consent from
all patients and Institutional Review Board approval. (b) Six-week-old primary plantar keratoacanthoma (KA) with a ulcerative-nodular aspect (IV:13). (c) Higher
magnification of tumor (20 mm). (d) Evolution of primary KA toward a verrucous tumor (IV:5). (e) Atrophic scar after complete regression of primary KA (IV:5).
(f) Multiple lesions in palmar skin showing over 12 KAs at various phases of development ranging from maturation, regression, to final pitted-scar stage (IV:20).
(g) Subungual lesion on the thumb. (h, i) Unilateral conjunctival KA (IV:13 and IV:14). Photographs are reproduced with permission from patients.
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primary palmoplantar and conjunctival
tumors. We anticipate that the causative
gene for MSPC will be rapidly identified
as awareness is raised about its exis-
tence and correct clinical diagnosis.
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Figure 2. Cancer development in patient IV:2 and mapping of multiple self-healing palmoplantar carcinoma (MSPC) to Chr. 17p. (a) Squamous cell carcinoma
(SCC) of the lower lip in patient IV:2 (20 mm). (b–d) Plantar ulceroburgeoning tumor after malignant transformation in patient IV:2 (50 mm). (e) After metastases and
bilateral leg amputations, histological section of the tibia revealed SCC infiltration to the bone tissue (bar¼ 50mm). (f) Identical-by-descent (IBD) mapping
following single-nucleotide polymorphism genotyping delineates one locus on chromosome 17p containing 288 genes shared by all 11 genotyped propositi.
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Disease Control in Cutaneous Leishmaniasis Is Independent
of IL-22
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TO THE EDITOR
Cutaneous leishmaniasis is a parasitic
disease caused by dermatotropic sub-
species of Leishmania. The disease
is endemic in several parts of the
world with approximately 12 million
people infected worldwide. In mice
and man, healing and lifelong protection
is mediated by IFNg-producing CD4þ
Th1 and CD8þ Tc1 cells, whereas Th2-
and regulatory T-cell (Treg)–associated
immune responses with high levels of
IL-4 and IL-10 are associated with a
non-healer phenotype (Sacks and Noben-
Trauth, 2002; Kautz-Neu et al., 2011).
Recently, we and others showed that
IL-17A contributes significantly to geneti-
cally determined disease susceptibility in
BALB/c mice, whereas lower levels of
IL-17A are detected in resistant C57BL/6
mice (Lopez Kostka et al., 2009;
Gonzalez-Lombana et al., 2013). As a
result, IL-17A-deficient BALB/c mice
were protected from progressive disease,
because, in wild types, IL-17A is respon-
sible for maintaining persisting neutrophil
infiltrates in BALB/c lesions associated
with impaired wound repair and parasite
killing, ultimately leading to parasite
visceralization. In humans, IL-17A and
nitric oxide release were negatively corre-
lated in self-healing lesions exhibiting high
nitric oxide and low IL-17A levels in
L. braziliensis infections (de Assis Souza
et al., 2013). In addition, IL-17A was
strongly associated with protection
against Kala Azar (Pitta et al., 2009).
Overall, these first results demonstrated
that, in addition to Th1/Th2 cells and Treg,
Th17 cells are also relevant for protection
against this important human pathogen.
Among the cytokines produced by
Th17 cells, IL-22 is most prominent.
Receptors to IL-22 are specifically
expressed by epithelial cells. Also, over-
expression of IL-22 has been demon-
strated to initiate skin inflammation. In
the present study, we addressed the role
of IL-22 in experimental cutaneous
leishmaniasis. First, murine experimen-
tal leishmaniasis was induced in resis-
tant C57BL/6 mice and susceptible
BALB/c mice using physiological low-Accepted article preview online 7 July 2014; published online 14 August 2014
Abbreviations: DC, dendritic cell; LACK, Leishmania homolog of receptors for activated C kinase;
LN, lymph node; Treg, regulatory T cell
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